CN102973597A - Peritoneal dialysis solution (containing lactate and low calcium) combination and preparation method thereof - Google Patents

Peritoneal dialysis solution (containing lactate and low calcium) combination and preparation method thereof Download PDF

Info

Publication number
CN102973597A
CN102973597A CN201210537606XA CN201210537606A CN102973597A CN 102973597 A CN102973597 A CN 102973597A CN 201210537606X A CN201210537606X A CN 201210537606XA CN 201210537606 A CN201210537606 A CN 201210537606A CN 102973597 A CN102973597 A CN 102973597A
Authority
CN
China
Prior art keywords
peritoneal dialysis
dialysis solution
preparation
sterilization
heating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210537606XA
Other languages
Chinese (zh)
Inventor
何光杰
袁英
凌可均
杨俊强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Jinyao Group Co Ltd
Original Assignee
Tianjin Jinyao Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Jinyao Group Co Ltd filed Critical Tianjin Jinyao Group Co Ltd
Priority to CN201210537606XA priority Critical patent/CN102973597A/en
Publication of CN102973597A publication Critical patent/CN102973597A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a peritoneal dialysis solution (containing lactate and low calcium) combination and a preparation method thereof. The peritoneal dialysis solution combination comprises the following components: 1.5%-4.0% of C6H12O6.H2O, 0.5%-0.6% of Cl2Na, 0.0001%-0.0002% of CaCl2, 0.00004%-0.00006% of MgCl2 and 0.4%-0.5% of C3H5NaO3. The preparation method is characterized in that the sterilization of a sub-packaged peritoneal dialysis solution is implemented by a method comprising the following steps of: firstly, heating the sub-packaged peritoneal dialysis solution to 115 DEG C by virtue of a hot-press sterilization method, and maintaining the sub-packaged peritoneal dialysis solution at 115 DEG C for 5 minutes; secondly, performing ultrasonic treatment on the peritoneal dialysis solution at a frequency of 20-50 kHz and an intensity of 5-20 W/cm<2> while the heating of the peritoneal dialysis solution begins; and thirdly, after the peritoneal dialysis solution is maintained at 115 DEG C for 5 minutes, stopping the heating and the ultrasonic treatment on the peritoneal dialysis solution, and cooling the peritoneal dialysis solution.

Description

Peritoneal dialysis solution (lactate) (low calcium) composition and method of making the same
Technical field
Peritoneal dialysis solution of the present invention and preparation method thereof.
Background technology
Peritoneal dialysis owing to compare with hemodialysis, have applied widely, dialytic efficiency is high, residual renal function is kept, the patients ' life quality advantages of higher, occupies more and more consequence in the alternative medicine of chronic renal failure.The key of successful peritoneal dialysis is the peritoneum that ultrafiltration function is good.Yet because the chronicity of peritoneal dialysis treatment, the ultrafiltration performance of peritoneum tends to be subjected to various factors to affect to change in therapeutic process, and this change is irreversible, finally can cause the forfeiture of patient's peritoneum ultrafiltration function, can't carry out abdomen again and thoroughly treat.Traditional peritoneal dialysis solution is mainly the GES of variable concentrations, produce peritoneal dialysis solution (lactate) and peritoneal dialysis solution (lactate) (low calcium) etc. such as Tianjin TianAn Medicine Industry Co., Ltd, when high temperature sterilize and storage, can decompose impurity such as producing 5 hydroxymethyl furfural (5-HMF) owing to contain the peritoneal dialysis solution of glucose, and existing studies show that, the glucose degradation products take 5-HMF as representative in the peritoneal dialysis solution (glucose degradation products, GDP) be that peritoneum is produced one of dysgenic key factor, in view of the chronicity of dialysis patient treatment, reducing as far as possible the GDP content take 5-HMF as representative in the peritoneal dialysis becomes and mainly needs the problem that solves in the prior art.
The ultrasonic sterilization technology is a kind of cold sterilization technology of sterilizing new that developed recently gets up, the fields such as food, drinking water and wastewater treatment have been applied to, China's document " ultrasound wave is inquired into several frequently seen pathogenic entero becteria killing effect and the mechanism of action thereof " (Fang Xiang etc., acoustic technique, the 4th phase of the 28th volume August in 2009, disclose in 491-494) when adopting ultrasonic sterilization technology and the collaborative sterilization of heating for some heat resistanceheat resistant effect preferably antibacterial do not produce synergy.
Summary of the invention
We find unexpectedly through research, select ultrasound wave in conjunction with the preparation technology of high temperature sterilize, can obtain the significantly reduced peritoneal dialysis solution of a kind of 5-HMF content.
The percentage ratio of the following stated all refers to percent weight in volume if no special instructions among the present invention.Wherein glucose is with C 6H 12O 6H 2The O meter, calcium chloride is with CaCl 22H 2The O meter, magnesium chloride is with MgCl 26H 2The O meter.
The invention provides a kind of peritoneal dialysis solution, the glucose that contains 1.5-4.0%, the sodium chloride of 0.5-0.6%, the calcium chloride of 0.0001-0.0002%, the magnesium chloride of 0.00004-0.00006%, and the sodium lactate of 0.4-0.5%, it is characterized in that adopting when described peritoneal dialysis solution is sterilized following method after packing:
1) adopts autoclaving, the peritoneal dialysis solution after the packing is warming up to 115 ℃, keep 5min;
2) beginning the while of heating up, peritoneal dialysis solution is imposed frequency 20-50kHz, intensity is 5-20W/cm 2Ultrasonic Treatment;
3) stopped heating and ultrasonic Treatment after step 1) is held time and arrived cool.
Described peritoneal dialysis solution, optimization formula are by 0.5377% sodium chloride, 0.000147% calcium chloride, and 0.0000508% magnesium chloride, 0.4483% sodium lactate, and 1.5% or 4.0% glucose, and the water for injection of surplus forms.
Described peritoneal dialysis solution, preferably adopt the following methods preparation:
1. dope preparation: get the water for injection of recipe quantity 10%, other compositions that enter recipe quantity are stirred to whole dissolvings.After, then add after medicinal charcoal 0.1 ~ 1% stirs, place to filter after 10 ~ 20 minutes and obtain dope.
2. medicinal liquid dilution: to dilute preparing tank, the supplementary injection water is to full dose with dope pressure filtration.Through 0.22 μ m ultimate filter be filtered to visible foreign matters qualified after embedding.
Preferably adopt inert gas shielding when preparation and embedding, described noble gas is selected from one or more in nitrogen or the carbon dioxide.
Described percent weight in volume is the ratio of adding active carbon weight with the prescription volume of the injection of preparing.
The specific embodiment
The transformation of sterilizing installation,
Sterilizing installation in the present invention, adopt the transformation of existing high temperature sterilize pot, the JT01-01-computer full-automatic fountain High Temperature High Pressure conditioning retorts that adopts the Jin Tai Zhucheng safe food machinery company limited of gold to produce, arrange ultrasonic oscillator around in autoclave, make the maximum ultrasonic intensity in the autoclave can reach 20w/cm 2, ultrasound wave adopts and the 40kHz specification.
Prescription described in the present embodiment is the inventory in 1000 bottles of injection.High temperature sterilize among the embodiment adopts the moist hear heat test sterilization under 115 ℃ of conditions without exception, adopt (the comparisons of several temperature indicators of steam sterilization such as Chen Jinqiu, China's Disinfection magazine, the 3rd phase of the 9th volume in 1992,186-187) disclosed content, (every bacterial content is 5 * 10 for culture presevation numbering ATCC7953, the production of Hangzhou Fu Jie Bioisystech Co., Ltd to select damp and hot pimelobacter sp sporeformer sheet 5~5 * 10 6Cfu, under 121 ℃ of saturated vapors sterilization testing conditions, D value is 1.3~1.9min) as the biological indicator, verifies the reliability of the compound moist heat sterilization method of ultrasound wave.
Example of formulations
Prescription is such as following table, and the packing specification is the 2000ml/ bag, and data are to amount to the prescription of every bag of dialysis solution in the table
Figure BDA0000257754041
1. dope preparation: get the water for injection of recipe quantity 10%, other compositions that add recipe quantity are stirred to whole dissolvings.After, then add after medicinal charcoal 0.1 ~ 1% stirs, place to filter after 10 ~ 20 minutes and obtain dope.
2. medicinal liquid dilution: to dilute preparing tank, the supplementary injection water is to full dose with dope pressure filtration.Through 0.22 μ m ultimate filter be filtered to visible foreign matters qualified after embedding.
When preparation and embedding, adopt nitrogen protection.
The sterilization effect confirmatory experiment
Get and respectively organize peritoneal dialysis solution by example of formulations method preparation, after filtration sterilization, before the packing, add bacillus stearothermophilus bacterium sheet biological indicator, add after the bacterium sheet broken up in sterile water for injection, addition is every 2000ml/ sheet, and each embodiment sterilising temp unification fixes on 115 ℃, and experiment grouping batch sees the following form
The experimental group numbering 1 2 3 4 5 6 7 8 9 10
115 ℃ of persistent period/min 3 3 5 5 7 7 10 10 10 15
Ultrasonic intensity/(W/cm 2 5 20 5 20 5 20 5 20 0 0
Each experimental group is all got 20 bags of injection, is respectively according to example of formulations 1-2 prescription preparation, 10 bags of each example of formulations.Stopped heating and ultrasonic after arriving heat time heating time is reduced to the injection temperature below 75 ℃ in 10min, takes out sample, base sampling under aseptic condition, cultivated 7 days with the cultivation that contains coeruleum bromocresolis, for being positive, detect sterilization effect with the culture medium flavescence, simultaneously, see the following form according to embodiment
The experimental group numbering 1 2 3 4 5 6 7 8 9 10
Positive rate 5 0 0 0 0 0 0 0 5 0
Can find out by sterilization experiment, when adopting the sterilization of ultrasound wave assisted with high-temperature, when being heated to 115 ℃ of 5min, can all kill thermoduric bacteria among the biological indicator, and when adopting high temperature sterilize separately, be heated at least the sterilization that 15min could be good.Illustrate that sterilizing methods provided by the invention can be on the basis that reduces high-temperature duration, the collaborative killing effect of the hot antibacterial that creates antagonism realizes reducing the effect that high-temperature duration can well be sterilized simultaneously.
The glucose degradation products contrast experiment
The grouping situation sees the following form
The experimental group numbering 1 3 5
The example of formulations numbering 2 2 2
The bag number 10 10 10
Wherein, wherein, experimental group 1 adopts the sterilization process of experimental group 4 in the sterilization effect confirmatory experiment, and experimental group 2 adopts the sterilization process of experimental group 10 in the sterilization effect confirmatory experiments, and experimental group 3 does not heat for matched group.
After experiment finishes, get respectively the sample detection 5-HMF content of experimental group 1-6.
Detection method is carried out absorbance detection according to the detection method under the Mannitol sodium chloride injection item in 2010 editions second one 94 pages of the Chinese Pharmacopoeias.
Testing result sees the following form
Numbering 1 3 5
Absorbance 0.108±0.012 0.215±0.018 0.079±0.010
Testing result shows, adopted the peritoneal dialysis solution of ultrasound wave in conjunction with the high-temperature sterilizing process preparation, can reduce significantly the glucose degradation products take 5-HMF as representative in the product, thereby reduce the saturating dialysis solution of abdomen to the toxicity of human body peritoneum, avoid causing the forfeiture of peritoneum ultrafiltration function, improve the safety of its life-time service.

Claims (2)

1. peritoneal dialysis solution, the glucose that contains 1.5-4.0%, the sodium chloride of 0.5-0.6%, the calcium chloride of 0.0001-0.0002%, the magnesium chloride of 0.00004-0.00006%, and the sodium lactate of 0.4-0.5%, it is characterized in that adopting when described peritoneal dialysis solution is sterilized following method after packing:
1) adopts autoclaving, the peritoneal dialysis solution after the packing is warming up to 115 ℃, keep 5min;
2) beginning the while of heating up, peritoneal dialysis solution is imposed frequency 20-50kHz, intensity is 5-20W/cm 2Ultrasonic Treatment;
3) stopped heating and ultrasonic Treatment after step 1) is held time and arrived cool.
2. peritoneal dialysis solution as claimed in claim 1, it is characterized in that filling a prescription is 0.5377% sodium chloride, 0.000147% calcium chloride, 0.0000508% magnesium chloride, 0.4483% sodium lactate, and 1.5% or 4.0% glucose, and the water for injection of surplus forms.
CN201210537606XA 2012-12-13 2012-12-13 Peritoneal dialysis solution (containing lactate and low calcium) combination and preparation method thereof Pending CN102973597A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210537606XA CN102973597A (en) 2012-12-13 2012-12-13 Peritoneal dialysis solution (containing lactate and low calcium) combination and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210537606XA CN102973597A (en) 2012-12-13 2012-12-13 Peritoneal dialysis solution (containing lactate and low calcium) combination and preparation method thereof

Publications (1)

Publication Number Publication Date
CN102973597A true CN102973597A (en) 2013-03-20

Family

ID=47848132

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210537606XA Pending CN102973597A (en) 2012-12-13 2012-12-13 Peritoneal dialysis solution (containing lactate and low calcium) combination and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102973597A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104666339A (en) * 2013-11-27 2015-06-03 天津金耀集团有限公司 Preparation method of peritoneal dialysis fluid (lactate) (low calcium) composition
CN104666335A (en) * 2013-11-27 2015-06-03 天津金耀集团有限公司 Preparation method of peritoneal dialysis solution (lactate) (low-calcium) composition
CN108310005A (en) * 2018-04-18 2018-07-24 浙江天瑞药业有限公司 A kind of peritoneal dialysis solution for resisting fibration of peritonaeum
CN110917422A (en) * 2019-12-05 2020-03-27 长春海伯尔生物技术有限责任公司 Ultrapure hemodialysis concentrated solution and preparation process thereof

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
《中华护理杂志》 19871231 戴解明 超声腹膜透析的护理 第245,249页 1-2 第22卷, 第6期 *
《广东药学》 19991231 钟智等 不同类型灭菌器灭菌对葡萄糖稳定性的影响 第32-35页 1-2 第9卷, 第2期 *
《温州医学院学报》 20020228 林光勇等 头孢吡肟在腹膜透析液中的稳定性观察 第57-58页 1-2 第32卷, 第1期 *
D. KNORR ETAL: "Nutritional improvement of plant foods by non-thermal processing", 《PROCEEDINGS OF THE NUTRITION SOCIETY》 *
戴解明: "超声腹膜透析的护理", 《中华护理杂志》 *
林光勇等: "头孢吡肟在腹膜透析液中的稳定性观察", 《温州医学院学报》 *
舒国伟等: "超声波在食品灭菌中的研究进展", 《中国调味品》 *
钟智等: "不同类型灭菌器灭菌对葡萄糖稳定性的影响", 《广东药学》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104666339A (en) * 2013-11-27 2015-06-03 天津金耀集团有限公司 Preparation method of peritoneal dialysis fluid (lactate) (low calcium) composition
CN104666335A (en) * 2013-11-27 2015-06-03 天津金耀集团有限公司 Preparation method of peritoneal dialysis solution (lactate) (low-calcium) composition
CN108310005A (en) * 2018-04-18 2018-07-24 浙江天瑞药业有限公司 A kind of peritoneal dialysis solution for resisting fibration of peritonaeum
CN110917422A (en) * 2019-12-05 2020-03-27 长春海伯尔生物技术有限责任公司 Ultrapure hemodialysis concentrated solution and preparation process thereof

Similar Documents

Publication Publication Date Title
CN102973597A (en) Peritoneal dialysis solution (containing lactate and low calcium) combination and preparation method thereof
CN110583681A (en) Chlorine-containing disinfectant and preparation method thereof
CN101890182A (en) Preparation method of medical hyaluronic acid gel preparation for sterilizing high-pressure steam
CN102973598A (en) Peritoneal dialysis liquid (lactate) composition and preparation method thereof
CN103766377A (en) Citric acid decalcified disinfectant applied to dialysis machinery and water treatment and preparation method of citric acid decalcified disinfectant
CN107550928A (en) A kind of glucose polymer peritoneal dialysis solution and its preparation technology
Dehghani et al. Sterilization of ginseng using a high pressure CO2 at moderate temperatures
CN2511304Y (en) Formaldehyde low-temperature steam sterilizing cupboard
CN105126158B (en) Polysaccharide fiber element hemostasis isolation antibacterial repairs glue and preparation method thereof
CN108992460A (en) A kind of preparation process of haemodialysis concentration B liquid
AU2012287895A1 (en) Inhibitory fiber against virulence factors production and method for producing same
CN101837010A (en) Preparation process of non-PVC soft-bag packing peritoneal dialysis solution and product thereof
CN102724872A (en) Disinfectant Composition
CN212593190U (en) Cotton fabric vacuum disinfection machine and cotton fabric vacuum disinfection system
CN109105368A (en) A kind of thermochemical sterilizing liquid for haemodialysis machine
CN110559457A (en) method for preparing medical ultrasonic coupling agent sterile product capable of being safely used
CN104013715A (en) Preparing method of cordate houttuynia/honeysuckle injection
CN104173384B (en) A kind of aseptic SIWEIZHENCENGBINGPENG DIYANYE of non-final sterilizing and preparation method
CN104083787B (en) Ethanol sterilizer
CN102552950A (en) Production process of unstable chemical injection
CN108653773A (en) A kind of sterilizing methods of Chinese medicine particulate matter
JP7038106B2 (en) Peritoneal dialysate
CN201631671U (en) Soft double-valve and double-layer sterile packaging infusion bag
CN201631673U (en) Double-layer aseptic package transfusion liquid
CN109550048B (en) Application of phenol safranine-mediated sonodynamic antibacterial chemotherapy in inhibiting activity of staphylococcus aureus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130320